Protalix BioTherapeutics, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 2 UNIVERSITY PLAZA, HACKENSACK, NJ, 07601
Mailing Address 2 UNIVERSITY PLAZA, HACKENSACK, NJ, 07601
Phone 201-696-9345
Fiscal Year End 1231
EIN 650643773
Financial Overview
FY2024
$8.31M
Net Income
$84.43M
Total Assets
$50.87M
Total Liabilities
$43.21M
Stockholders' Equity
$0.04
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 11, 2026 | View on SEC |
| 8-K Current report of material events | January 30, 2026 | View on SEC |
| 8-K Current report of material events | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | December 23, 2025 | View on SEC |
| 4 Insider stock transaction report | November 19, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| 8-K Current report of material events | November 13, 2025 | View on SEC |
| 8-K Current report of material events | November 3, 2025 | View on SEC |
| 8-K Current report of material events | October 17, 2025 | View on SEC |
| 4 Insider stock transaction report | September 4, 2025 | View on SEC |
Insider Trading
BUY 2 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.